Mail

UK markets closed

FTSE 100
8,433.76
+52.41(+0.63%)
FTSE 250
20,645.38
+114.08(+0.56%)
AIM
789.87
+6.17(+0.79%)
GBP/EUR
1.1622
+0.0011(+0.09%)
GBP/USD
1.2525
+0.0001(+0.01%)
Bitcoin GBP
48,633.79
+9.39(+0.02%)

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

Teva Pharmaceutical Industries Limited (TEV.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR

Add to watchlist

15.10

+0.20

(+1.34%)

At close: 05:06PM CEST

Currency in EUR

Valuation measures⁴

Market cap (intra-day)	16.53B
Enterprise value	32.26B
Trailing P/E	855.98
Forward P/E	6.84
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.14
Price/book (mrq)	2.53
Enterprise value/revenue	1.95
Enterprise value/EBITDA	149.55

Trading information

Stock price history

Beta (5Y monthly)	1.05
52-week change ³	98.68%
S&P500 52-week change ³	26.27%
52-week high ³	15.25
52-week low ³	6.64
50-day moving average ³	12.68
200-day moving average ³	10.26

Share statistics

Avg vol (3-month) ³	6.3k
Avg vol (10-day) ³	10.48k
Shares outstanding ⁵	1.13B
Implied shares outstanding ⁶	1.13B
Float ⁸	1.13B
% held by insiders ¹	0.00%
% held by institutions ¹	49.98%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	2.98
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	27 Nov 2017
Last split factor ²	100:1
Last split date ³	01 Jul 2004

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	-2.99%
Operating margin (ttm)	17.28%

Management effectiveness

Return on assets (ttm)	4.84%
Return on equity (ttm)	-9.67%

Income statement

Revenue (ttm)	16B
Revenue per share (ttm)	14.28
Quarterly revenue growth (yoy)	4.30%
Gross profit (ttm)	N/A
EBITDA	4.46B
Net income avi to common (ttm)	-478M
Diluted EPS (ttm)	-0.39
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	2.99B
Total cash per share (mrq)	2.64
Total debt (mrq)	19.94B
Total debt/equity (mrq)	264.33%
Current ratio (mrq)	0.89
Book value per share (mrq)	6.43

Cash flow statement

Operating cash flow (ttm)	1.39B
Levered free cash flow (ttm)	3.57B